|
 Contact us regarding Duragesic; attorney consultations are free.
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. read more »
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature read more »
Dec. 31, 05: Families sue over alleged pain patch deaths
SALT LAKE CITY -- Surviving family members of two Utah women have filed federal suits against the manufacturers of a pain medication skin patch, which they say leaked and caused the deaths of both wom... read more »
What is Duragesic?
Duragesic, known generically as the fentanyl transdermal system, is marketed by Janssen Pharmaceutica Products, L.P., a subsidiary of Johnson and Johnson. Duragesic is a pain medication in the form of a patch that is attached to the skin of the patient. The patch contains a strong narcotic, fentanyl, which is a Schedule II opioid agonist. Fentanyl is contained in the patch in the form of a gel, and this pain medication is absorbed through the patient's skin. Duragesic is prescribed for individuals who suffer from long periods of chronic pain, possibly exceeding a few weeks or longer, and who require strong pain medication around the clock. Duragesic was the first painkiller patch to receive approval in 1990.
Contact us regarding Duragesic; attorney consultations are free.
« Back to Duragesic page
|
|
| | |
